Method for treating neurodegenerative diseases. The present invention relates, in general, to a composition or kit comprising an angiogenic factor for treating neurodegenerative diseases, to reverse the toxic effect produced by the beta-amyloid protein (1-42) or the hyperphosphorylated tau-protein, to reduce the quantity of hyperphosphorylated tau-protein and/or prevent the formation of neurofibrillary tangles.